Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/42341
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Ram S-
dc.contributor.authorWalia, Amandeep K-
dc.contributor.authorPratibha-
dc.contributor.authorKhattar, Jasvirinder S-
dc.contributor.authorSingh, Davinder P-
dc.date.accessioned2017-07-05T05:36:09Z-
dc.date.available2017-07-05T05:36:09Z-
dc.date.issued2017-07-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/42341-
dc.description514-522en_US
dc.description.abstractLectins, proteins mainly of plant origin, possess anti-HIV, anti-inflammatory, antimicrobial, antinociceptive, antiproliferative, antitumour and antiviral properties. Further, they are useful tools in biomedical research, have potent mitogenic potential, and also play a vital role in various biological processes, particularly in host defense mechanisms. The beneficial nature of lectins is often attributed to their ability to agglutinate cells through sugar-specific binding sites. Here, we screened cyanobacterial species for occurrence of surface bound lectins and evaluated their carbohydrate specificity. Eleven cyanobacterial species were screened for lectins using human, pig, sheep, goat and rabbit erythrocytes. Amongst them, only five organisms, namely Anabaena naviculoides RFKK3, Anabaena torulosa RFGB5, Anabaena variabilis RFTM22, Desmonostoc muscorum RFKK18 and Synechocystis sp. RFDB50 were found to possess cell surface lectins. These lectins showed non-specific agglutination towards animal (rabbit, pig, sheep and goat) and human (ABO) erythrocytes. Neuraminidase treated human blood type-O erythrocytes enhanced the lectin activity of Anabaena naviculoides RFKK3, Anabaena torulosa RFGB5, Anabaena variabilis RFTM22, Desmonostoc muscorum RFKK18, while protease treated human blood type-O erythrocytes enhanced the lectin activity of only Anabaena variabilis RFTM22 and Desmonostoc muscorum RFKK18. Lectin activity of Synechocystis sp. RFDB50 remained unaltered with enzymatically treated human blood type-O erythrocytes. A panel of sugars were tested for inhibition of lectin activity. Lectins from majority of the test organisms were found to be inhibited by glycoproteins, bovine submaxillary mucin and porcine stomach mucin. Simple sugars and derivatives were non-inhibitory towards Anabaena variabilis RFTM22 lectin activity. This indicates that cyanobacterial lectins possess unique glycoprotein binding specificities. Anabaena naviculoides RFKK3 and Anabaena torulosa RFGB5 cultures showed maximum lectin activity during log phase of growth. Anabaena variabilis RFTM22 and Desmonostoc muscorum RFKK18 cultures expressed maximum lectin activity during stationary phase of growth. However, Synechocystis sp. RFDB50 expressed lectin activity only during log phase of growth. Literature survey reveals, this is the first report on cell surface lectins from cyanobacteria.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.55(07) [July 2017]en_US
dc.subjectAlgal lectin databaseen_US
dc.subjectAnabaena naviculoidesen_US
dc.subjectA. torulosaen_US
dc.subjectA. variabilisen_US
dc.subjectAsialofetuinen_US
dc.subjectCarbohydrate recognition domains (CRD)en_US
dc.subjectDesmonostoc muscorumen_US
dc.subjectHaemagglutinationen_US
dc.subjectMicrocystis aeruginosaen_US
dc.subjectM. viridisen_US
dc.subjectMucinen_US
dc.subjectNeuraminidaseen_US
dc.subjectNostoc ellipsosporumen_US
dc.subjectOscillatoria agardhiien_US
dc.subjectScytonema variumen_US
dc.subjectSynechocystis sp.en_US
dc.subjectWestiellopsis sp.en_US
dc.titleNew cell surface lectins with complex carbohydrate specificity from cyanobacteriaen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.55(07) [July 2017]

Files in This Item:
File Description SizeFormat 
IJEB 55(7) 514-522.pdf555.91 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.